CHEST WALL DISEASE

Clinical trials for CHEST WALL DISEASE explained in plain language.

Never miss a new study

Get alerted when new CHEST WALL DISEASE trials appear

Sign up with your email to follow new studies for CHEST WALL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Immunotherapy combo tested in Tough-to-Treat breast cancer

Disease control Completed

This study tested if adding an immunotherapy drug (pembrolizumab) to a standard chemotherapy (carboplatin) could better control breast cancer that had returned to the chest wall. It involved 76 patients whose cancer had stopped responding to prior hormone therapies or was a type …

Matched conditions: CHEST WALL DISEASE

Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

CHEST WALL DISEASE

Get alerted when new CHEST WALL DISEASE trials appear

Immunotherapy combo tested in Tough-to-Treat breast cancer